Publications by authors named "Andrew W Stephens"

Claim this Profile
T
Technology and Dementia Preconference.
Jonas Marquardt, Niklas Vockert, Niklas Behrenbruch, Beate Schumann-Werner, Anne Hochkeppler, Andrew W Stephens

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's Imaging Consortium.
Leonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, Prithvi Arunachalam, Craig Ritchie, Andrew W Stephens

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's Imaging Consortium.
Alexis Moscoso, Antoine Leuzy, Lars Lau Raket, Victor L Villemagne, Gregory Klein, Andrew W Stephens, Diane Stephenson

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a novel reference region for [F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies.
Lukas Frontzkowski, Johannes Gnörich, Mattes Gross, Amir Dehsarvi, Sebastian N Roemer-Cassiano, Andrew W Stephens

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortical thickness subtypes in cognitively unimpaired individuals: Differential network and transcriptomic vulnerability to cortical thinning.
Luigi Lorenzini, Mario Tranfa, Leonard Pieperhoff, Federico Masserini, Mara Ten Kate, Andrew W Stephens

Alzheimers Dement· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study.
Guilherme Domingues Kolinger, Oscar Sotolongo-Grau, Núria Roé-Vellvé, Juan Pablo Tartari, Ángela Sanabria, Andrew W Stephens

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry.
Clément Morgat, Heying Duan, Simone Dalm, Elif Hindié, Thomas Günther, Andrew W Stephens

J Nucl Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-parametric [F]PI-2620 tau PET/MRI for the phenotyping of different Alzheimer's disease variants.
Michael Rullmann, Dylan Henssen, Juliana T Melasch, Cordula Scherlach, Dorothee Saur, Andrew W Stephens

Eur J Nucl Med Mol Imaging· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility, Costs and Cost-Utility of Amyloid-PET in the Diagnostic Process of Memory Clinic Patients: A Trial-Based Economic Evaluation From AMYPAD-DPMS.
Ingrid S van Maurik, Daniele Altomare, Lyduine E Collij, Camilia Caprioglio, Christian Moro, Andrew W Stephens

Eur J Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum.
Sharmila Dorbala, Rosalyn Adigun, Kevin M Alexander, Michela Brambatti, Sarah A M Cuddy, Andrew W Stephens

JACC Cardiovasc Imaging· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Head-to-Head Comparison of [F]GTP1 with [F]MK-6240 and [F]PI-2620 in Alzheimer Disease.
Emily Olafson, Matteo Tonietto, Gregory Klein, Edmond Teng, Andrew W Stephens

J Nucl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Centiloid recommendations for clinical context-of-use from the AMYPAD consortium.
Lyduine E Collij, Ariane Bollack, Renaud La Joie, Mahnaz Shekari, Santiago Bullich, Andrew W Stephens

Alzheimers Dement· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization Insights.
Aleksandar Jovalekic, Santiago Bullich, Núria Roé-Vellvé, Guilherme Domingues Kolinger, Lorelei R Howard, Andrew W Stephens

Pharmaceuticals (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative and quantitative analysis of 18F-GP1 positron emission tomography in thrombotic cardiovascular disease.
Beth Whittington, Evangelos Tzolos, Shruti Joshi, Rong Bing, Jack Andrews, Andrew W Stephens

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-head comparison of tau PET tracers [F]PI-2620 and [F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort.
Matteo Tonietto, Oscar Sotolongo-Grau, Núria Roé-Vellvé, Santiago Bullich, Juan Pablo Tartari, Andrew W Stephens

Alzheimers Res Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model.
Antoine Leuzy, Lars Lau Raket, Victor L Villemagne, Gregory Klein, Matteo Tonietto, Andrew W Stephens

Alzheimers Dement· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
Merle Hönig, Daniele Altomare, Camilla Caprioglio, Lyduine Collij, Frederik Barkhof, Andrew W Stephens

Neurology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Neurofilament Light Chain, [F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS.
Carla Palleis, Nicolai Franzmeier, Endy Weidinger, Alexander M Bernhardt, Sabrina Katzdobler, Andrew W Stephens

Neurology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods.
Aleksandar Jovalekic, Núria Roé-Vellvé, Norman Koglin, Mariana Lagos Quintana, Aaron Nelson, Andrew W Stephens

Eur J Nucl Med Mol Imaging· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive In Vivo Thrombus Imaging in Patients With Ischemic Stroke or Transient Ischemic Attack-Brief Report.
Beth Whittington, Evangelos Tzolos, Rong Bing, Jack Andrews, Christophe Lucatelli, Andrew W Stephens

Arterioscler Thromb Vasc Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive In Vivo Coronary Artery Thrombus Imaging.
Evangelos Tzolos, Rong Bing, Jack Andrews, Mark G MacAskill, Adriana A S Tavares, Andrew W Stephens

JACC Cardiovasc Imaging· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
Daniele Altomare, Frederik Barkhof, Camilla Caprioglio, Lyduine E Collij, Philip Scheltens, Andrew W Stephens

JAMA Neurol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic setting.
Ingrid S van Maurik, Hana M Broulikova, Arenda Mank, Els D Bakker, Arno de Wilde, Andrew W Stephens

Alzheimers Dement· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data.
Anna Ballweg, Carolin Klaus, Letizia Vogler, Sabrina Katzdobler, Karin Wind, Andrew W Stephens

J Neuroinflammation· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline.
Camilla Caprioglio, Federica Ribaldi, Leonie N C Visser, Carolina Minguillon, Lyduine E Collij, Andrew W Stephens

JAMA Netw Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis